« iepriekšējāTurpināt »
Bain, James A., Ph. D., director, Division of Basic Health Sciences,
Brennan, Bruce J., vice president and general counsel, Pharmaceutical
Brill, Dr. Henry, chairman, Committee on Alcoholism and Drug
Chayet, Neil L., lecturer in legal medicine at the Boston University
Cole, Dr. Jonathan O., chairman, Committee for Effective Drug
Corman, Hon. James C., a Representative in Congress from the
David, Clifford C., legislative counsel, Smith Kline & French Laboratories_
de la Garza, Hon. Kika, a Representative in Congress from the State of Texas.
Dean, John W., III, Associate Deputy Attorney General, Department of Justice.__.
Denney, Hon. Robert V., a Representative in Congress from the State
Dobbs, Dr. Dorothy, Director, Marketed Drugs Division, Bureau of
Egeberg, Dr. Roger O., Ássistant Secretary for Health and Scientific
Farabee, Dr. Dale, secretary, National Association of State Mental
Farnsworth, Dana L., director, University Health Services, Harvard
Fletcher, Donald K., manager of distribution protection, Smith
Freedman, Dr. Daniel X., professor and chairman, Department of
Freeland, Michael E., associate director, National Association for
Gallagher, Hon. Cornelius E., a Representative in Congress from the
Giaimo, Hon. Robert N., a Representative in Congress from the State
Gibson, Dr. Merle, Director, New Drugs Division, Bureau of Drugs,
Goddard, Dr. James L., on behalf of the American Public Health
Goodrich, William, General Counsel, Bureau of Drugs, Food and
Griffith, Dr. John D., assistant professor, Psychiatry and Pharma-
Hanna, Hon. Richard T., a Representative in Congress from the State of California....
Griffiths, Hon. Martha W., a Representative in Congress from the
Ingersoll, John E., Director, Bureau of Narcotics and Dangerous
Hunt, Hon. John E., a Representative in Congress from the State of
79, 82, 675
Jaffe, Dr. Jerome H., associate professor of psychiatry, University of
Jennings, Dr. John, Acting Director, Bureau of Drugs, Food and Drug Administration, Public Health Service, Department of Health, Education, and Welfare.
Johnson, Hon. Harold T. (Bizz), a Representative in Congress from
Klein, Dr. Donald F., director of research, Hillside Hospital, Glen
Kline, Dr. Nathan S., New York, N. Y.
Lewis, Dr. Edward, Chief Medical Officer, Bureau of Narcotics and
Lipton, Dr. Morris A., professor and chairman, Department of Psy-
Mark, Ralph and Frances, Poughkeepsie, N. Y
Meyer, Dr. Roger, School of Medicine, Boston University, former chief, Center for Studies of Narcotics and Drug Abuse, National Institute of Mental Health_
Mikva, Hon. Abner J., a Representative in Congress from the State of
Miller, Dr. Morton G., Associate Director for Special and Collabora-
Mink, Hon. Patsy T., a Representative in Congress from the State of
Mitchell, Hon. John N., Attorney General, Department of Justice,
Moss, Sanford, in behalf of American Psychiatric Association..
Patton, William D., assistant general counsel, Pharmaceutical Manu-
Pepper, Hon. Claude, a Representative in Congress from the State of
Peterson, Harry N., attorney, legislative department, American
Pettis, Hon. Jerry L., a Representative in Congress from the State of
Podell, Hon. Bertram L., a Representative in Congress from the State
Roberts, Carl, director, legal division, American Pharmaceutical
Schnibbe, Harry C., executive director, National Association of State
Schuster, Charles R., Ph. D., associate professor of psychiatry and
Speiser, Lawrence, director, Washington (D.C.) Office, American Civil
Stoddard, Ezekial G., special counsel, Pharmaceutical Manufacturers
Thompson, Hon. Frank, Jr., a Representative in Congress from the
Van Deerlin, Hon. Lionel, a Representative in Congress from the State of California_
Vigorito, Hon. Joseph P., a Representative in Congress from the State of Pennsylvania__
Waldie, Hon. Jerome R., a Representative in Congress from the State of California_.
West, Dr. Louis Jolyon, trustee, American Psychiatric Association.. Wilson, Hon. Charles H., a Representative in Congress from the State of California..
Woods, William E., Washington representative, National Association
Wright, Mrs. J. Skelly, secretary, National Association for Mental
Yolles, Dr. Stanley F., Director, National Institute of Mental Health,
American Academy of Pediatrics, Robert G. Frazier, M.D., executive
Changes suggested in H.R. 13743, "The Controlled Depressant
Letter dated March 11, 1960, to Chairman Jarman re present
"Pharmacognosy and Chemistry of 'Canabis sativa" ", by Norman
American Psychiatric Association:
Barton, Walter E., M.D., medical director, letter dated June 16,
Curriculum vitae Daniel X. Freedman, M.D..
Position paper on drug abuse and the need to separate medical
Ayd, Dr. Frank J., Jr., biographical sketch__-
Burks, Thomas F., Ph. D., assistant professor, School of Medicine,
executive director, letter dated March 17, 1970, to Subcommittee on
Council of Health Organizations:
Article from New York Times entitled "3 Health Groups Combine
Extract from the proceedings of the Council of Health Organiza-
Daniel, Hon. Price, former U.S. Senator and Governor of Texas, statement with "The Illicit Narcotics Traffic," Senate Report No. 1440, dated January 23, 1956, attached.
De Jong, Jacob, M.D., psychiatrist, Newtown, Conn., letter dated
Eli Lilly & Co., H. F. DeBoest, vice president, corporate affairs, statement._.
Additional material submitted for the record by-Continued
Ferraro, Douglas P., Ph. D., associate professor, Department of Psychology, University of New Mexico, letter dated March 11, 1970, to Congressman Manuel Lujan of New Mexico, with forwarding letter.
Hanna, Hon. Richard T., a Representative in Congress from the State
Article from the Santa Ana (Calif.) Register entitled "No Knock
Article from the Los Angeles (Calif.) Times entitled " 'No-Knock'
Health, Education, and Welfare Department:
Characteristics of amphetamine drug dependence..
Letter dated March 3, 1970, from Secretary Finch to Chairman
Letter dated March 30, 1970, from Dr. Roger O. Egeberg, to
Letter dated April 30, 1970, from M. J. Ryan, Acting Director,
Status of feneluramine__
Usefulness of amphetamines in epilepsy-
Usefulness of amphetamines in hospitalized psychopaths... Hoffman-La Roche Inc., Dr. V. D. Mattia, president and chief executive officer:
Hollister, Leo E., M.D., associate chief of staff, Veterans' Administration Hospital, Palo Alto, Calif., statement
Hunt, Hon. John E., a Representative in Congress from the State of New Jersey, condensed excerpts of testimony of John E. Ingersoll, Director, Bureau of Narcotics and Dangerous Drugs, on the subject of drug abuse S. 3246..
Institute of Living, Research Laboratories, Bernard C. Glueck, Jr., M.D., director of research, letter dated February 2, 1970, to Chairman Staggers
Irwin, Samuel, Ph. D., professor of pharmacology, Department of Psychiatry, University of Oregon Medical School, letter dated February 19, 1970, to Mr. W. E. Williamson, clerk, House Committee on Interstate and Foreign Commerce, with attached papers entitled "Controlled Dangerous Substances Act" and "Drugs of Abuse: Their Actions and Relative Hazard Potential”.
Actual case which points out the need for agents to have the
Depressant and stumulant drugs; proposed listing of additional
Dangerous Drugs to implement and administer the proposed
Estimated registration fees - - - -
Justification for placement of alphacetylmethadol in schedule I
Members of the Scientific Advisory Committee on Drugs.
Additional material submitted for the record by-Continued
White House Interdepartmental Committee on Drug Use and
Why no performance bonds are required under section 602b---.
"Introduction-The Psychology, Philosophy, Mortality and
Number of resident patients in State and local government mental
"The Successful Treatment of Narcotic Addiction With Anti-
Memorandums from Herbert H. Rozoff Associates Inc., Chicago,
"Study sees glue sniffing as worse than pot"-by Gerry Keir.. National Association of Chain Drug Stores, Robert J. Bolger, executive vice president, statement.
National Association of Retired Civil Employees, Thomas G. Walters, president, statement..
New York Academy of Medicine, John L. Pool, M.D., president, letter dated March 13, 1970, to Chairman Jarman, with attachments
Nix, J. T., M.D., Ph. D., medical research director Nix Foundation for Medical Research and member, Louisiana Narcotics Rehabilitation Commission, letter dated March 23, 1970, to Representative Hale Boggs, with forwarding letter to Chairman Staggers-O'Donnell, John A., University of Kentucky, Department of Sociology and Rural Sociology, letter dated Febraury 13, 1970, to Congressman Watts of Kentucky, with forwarding letter to Chairman Staggers--
Pepper, Hon. Claude, a Representative in Congress from the State of Florida:
Amendment No. 451 to S. 3246_
"Crime in America-Why 8 Billion Amphetamines?", hearings
Federal-State cooperation in drug abuse enforcement..
Salk Institute, Joseph E. Slater, president, and Jacob Bronowski, Di-
Sargent, Thornton, III, Ph. D., Berkelye, Calif., letter dated February
Wisconsin Department of Health and Social Services, Arnold M.